Literature DB >> 16800034

Protein Equalizer Technology : the quest for a "democratic proteome".

Pier Giorgio Righetti1, Egisto Boschetti, Lee Lomas, Attilio Citterio.   

Abstract

No proteome can be considered "democratic", but rather "oligarchic", since a few proteins dominate the landscape and often obliterate the signal of the rare ones. This is the reason why most scientists lament that, in proteome analysis, the same set of abundant proteins is seen again and again. A host of pre-fractionation techniques have been described, but all of them, one way or another, are besieged by problems, in that they are based on a "depletion principle", i.e. getting rid of the unwanted species. Yet "democracy" calls not for killing the enemy, but for giving "equal rights" to all people. One way to achieve that would be the use of "Protein Equalizer Technology" for reducing protein concentration differences. This comprises a diverse library of combinatorial ligands coupled to spherical porous beads. When these beads come into contact with complex proteomes (e.g. human urine and serum, egg white, and any cell lysate, for that matter) of widely differing protein composition and relative abundances, they are able to "equalize" the protein population, by sharply reducing the concentration of the most abundant components, while simultaneously enhancing the concentration of the most dilute species. It is felt that this novel method could offer a strong step forward in bringing the "unseen proteome" (due to either low abundance and/or presence of interference) within the detection capabilities of current proteomics detection methods. Examples are given of equalization of human urine and serum samples, resulting in the discovery of a host of proteins never reported before. Additionally, these beads can be used to remove host cell proteins from purified recombinant proteins or protein purified from natural sources that are intended for human consumption. These proteins typically reach purities of the order of 98%: higher purities often become prohibitively expensive. Yet, if incubated with "equalizer beads", these last impurities can be effectively removed at a small cost and with minute losses of the main, valuable product.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800034     DOI: 10.1002/pmic.200500904

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  44 in total

1.  Proteomic technologies for the discovery of type 1 diabetes biomarkers.

Authors:  Wenbo Zhi; Sharad Purohit; Colleen Carey; Meiyao Wang; Jin-Xiong She
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

2.  A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS.

Authors:  Haige Ye; Li Sun; Xiaojun Huang; Ping Zhang; Xiaoshu Zhao
Journal:  Mol Cell Biochem       Date:  2010-06-05       Impact factor: 3.396

Review 3.  Proteomics: a pragmatic perspective.

Authors:  Parag Mallick; Bernhard Kuster
Journal:  Nat Biotechnol       Date:  2010-07-09       Impact factor: 54.908

4.  Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome.

Authors:  Chengjian Tu; Jun Li; Rebeccah Young; Brian J Page; Frank Engler; Marc S Halfon; John M Canty; Jun Qu
Journal:  Anal Chem       Date:  2011-05-26       Impact factor: 6.986

Review 5.  Quantitative matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  Mark W Duncan; Heinrich Roder; Stephen W Hunsucker
Journal:  Brief Funct Genomic Proteomic       Date:  2008-09

6.  In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.

Authors:  Emmanuelle Mouton-Barbosa; Florence Roux-Dalvai; David Bouyssié; François Berger; Eric Schmidt; Pier Giorgio Righetti; Luc Guerrier; Egisto Boschetti; Odile Burlet-Schiltz; Bernard Monsarrat; Anne Gonzalez de Peredo
Journal:  Mol Cell Proteomics       Date:  2010-01-21       Impact factor: 5.911

Review 7.  Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies.

Authors:  Andrei Turtoi; Edwin De Pauw; Vincent Castronovo
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

8.  Targeting deeper the human serum fucome by a liquid-phase multicolumn platform in combination with combinatorial peptide ligand libraries.

Authors:  Subhashini Selvaraju; Ziad El Rassi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-30       Impact factor: 3.205

Review 9.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

10.  Biomarker discovery in animal health and disease: the application of post-genomic technologies.

Authors:  Rowan E Moore; Jennifer Kirwan; Mary K Doherty; Phillip D Whitfield
Journal:  Biomark Insights       Date:  2007-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.